In the last month, the IU Precision Health Initiative has been in the news for several different research projects.
Precision Health News
Researchers across the state have been keeping a close eye on the COVID-19 pandemic, as Indiana continues the reopening process. The Regenstrief Institute put together an updated dashboard to track trends.
Although our Precision Health Initiative (PHI) teams would prefer to be working as usual during this time, they are skillfully adjusting to the ever-changing conditions presented by the COVID-19 pandemic, while keeping an eye fixed toward future progress. We did a quick round up with the disease team leaders to see what research is still ongoing.
Team science is a collaborative effort that leverages the strengths and expertise of professionals trained in different areas to address a scientific challenge. While team science may seem intuitive, it’s a relatively new approach to conducting research, given that historically, single investigator-driven approaches are ideal for many scientific endeavors.
As the COVID-19 situation across Indiana changes and evolves, researchers at Regenstrief Institute are developing more accurate models to help state leaders make the best decisions possible. Shaun Grannis, MD, is part of the team keeping a watchful eye on the data.
While many research projects across the state are currently in hibernation mode due to the COVID-19 pandemic, some teams are adjusting their scope to incorporate the coronavirus into their work.
On Friday afternoon, Aaron Carroll, MD, joined the conversation on the Indiana University Facebook page to do a live question and answer session about COVID-19. Carroll is the host of the Healthcare Triage podcast, which is sponsored by the Precision Health Initiative and IU School of Medicine.
Within the first three weeks of opening recruitment for the Phase I gestational diabetes study in Evansville, three patients have signed up to take part. All three are now enrolled in the study known as Hoosier Moms, which focuses on women who are currently pregnant, to help researchers better understand the risks that could lead to gestational diabetes, and eventually to the prevention of Type 2 diabetes.
March is Multiple Myeloma Awareness Month and the Precision Health Initiative (PHI) multiple myeloma disease research team is working toward a cure for the disease. Multiple myeloma is a kind of blood cancer. Most patients are diagnosed using a simple blood test after showing symptoms including high amounts of calcium, renal failure, anemia and bone disease.
Colorectal cancer is the third leading cause of cancer-related deaths for both men and women in the United States, according to the American Cancer Society. Screening can save lives, but the rate of screening for colorectal cancer is low, less than 65 percent, which means thousands of people die unnecessarily every year. Peter H. Schwartz, MD, PhD, hopes to make an impact on that issue by using precision health, specifically by providing patients with information about their individual risk factors.